AHR Price Prediction Next Week
Technical Analysis
Current price of AHR is $27.75 as of February 24, 2025. Technical indicators show:
- RSI (14) at 46.12 indicates neutral momentum
- MACD (-0.18) showing bearish divergence with negative histogram
- Stock trading below 5-day SMA ($27.72) and 10-day SMA ($27.87), suggesting short-term weakness
- Bollinger Bands show price near lower band, with BB% at 0.34 indicating potential oversold condition
News Impact
Recent positive catalysts:
- Strong growth prospects highlighted by RBC Capital Markets
- Quarterly dividend of $0.25 announced, representing 3.49% annualized yield
- Stock price has grown 145% since NYSE listing in February 2024
Price Prediction (Next Week)
Based on Fibonacci levels and technical indicators:
- Resistance levels: $28.95, $29.58, $30.60
- Support levels: $26.90, $26.27, $25.25
- Pivot point: $27.93
Trading Recommendation
SELL with target price of $26.90 (first support level) due to:
- Bearish MACD crossover
- Trading below key moving averages
- Negative momentum indicated by declining RSI
- Potential profit-taking after strong one-year performance
Set stop loss at $28.95 (first resistance) to limit downside risk.
AHR Similar Chart Price Prediction
The price of AHR is predicted to go up -9.21%, based on the high correlation periods with CFFN. The similarity of these two price pattern on the periods is 91.21%.
AHR
CFFN
Down: -9.21%Similarity: 91.21%
AHR Revenue Forecast
AHR EPS Forecast
AHR FAQs
What is bull’s view on AHR?
What is bear's view on AHR?
What is AHR revenue forecast for next quarter？
AHR Analyst's Forecast
Ronald Kamdem
Morgan Stanley
Buy
2024-12-30
Price Target
$27 → $29
Upside
+2.96%
Morgan Stanley raised the firm's price target on American Healthcare REIT to $29 from $27 and keeps an Overweight rating on the shares after updating estimates to reflect Q3 earnings and mark to market the multiple based on where healthcare peers have traded.
Michael Carroll
RBC Capital
Buy
2024-11-18
Price Target
$28 → $30
Upside
+9.57%
